Advertisement

Topics

Cord Blood America Company Profile

05:59 EST 11th December 2018 | BioPortfolio

Cord Blood America's mission is to be the most respected stem cell preservation company in the world. Cord Blood America will achieve its mission through educating expectant parents, families with a history of disease, critically ill patients, and all others who wish to learn about this life saving opportunity. We will provide constant care and support to the families whose stem cells we preserve, and to the medical professionals who help them do so. We are joined in the fight to combat life-threatening illness by educating one person at a time. Founded in summer 2002 and operational on January 1, 2003, Cord Partners, a Cord Blood America company, has established itself as a platinum standard national competitor in the umbilical cord blood storage industry. Cord Partners was founded by Matthew L. Schissler, Chairman and CEO, Stephanie Schissler, former President & COO and who is a consultant to the company, and Laura Fitzpatrick, former Vice President of Strategic Relations.

Location

9000 W. Sunset Boulevard
Suite 400
Los Angeles
CA
90069
United States of America

Contact

Phone: 310.432.4090
Fax: 310.432.4098
Email: investors@cordblood-america.com


News Articles [1513 Associated News Articles listed on BioPortfolio]

Expanded cord blood shows potential for use in adult bone marrow transplants

(Duke University Medical Center) Umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe...

New technology transforming blood & stem cell collection

(Trinity PR) A new cord blood processing technology, Toticyte, developed by the UK's leading blood cord bank, Cells4life, has been launched to midwives and healthcare professionals.

The Future of Cord Blood and Perinatal Stem Cells

The stem cells found in umbilical cord blood are hematopoietic stem cells (HSCs), which can help in the replenishment of a depleted blood supply by providing new, healthy cells in the case of certain ...

Epidural stimulation leads to recovery of cardiovascular function in spinal-cord-injured

(University of Louisville) Four research participants with chronic, complete cervical spinal cord injury, persistent low resting blood pressure and blood pressure decrease when sitting up experienced ...

Canadian Cord-Blood Procedure Passes Key Milestone in Cancer Trial

(The Globe and Mail) – Researchers behind a made-in-Canada technology for multiplying the number of stem cells that can be derived from donated cord blood say they are ready to move on to the ne...

Research uncovers new approach for expanding stem cells from umbilical cord blood

Researchers from the Stowers Institute for Medical Research and collaborators have identified a way to expand blood-forming, adult stem cells from human umbilical cord blood.

AMAG divests its Cord Blood Registry division to GI Partners for $530mm

Private equity firm GI Partners agreed to acquire AMAG Pharmaceuticals Inc.'s Cord Blood Registry Inc. (CBR) unit, a newborn stem cell banking company.

AMAG Pharma completes divestiture of Cord Blood Registry to GI Partners

AMAG Pharmaceuticals, Inc has closed the previously announced divestiture of Cord Blood Registry (CBR) to GI Partners, a private equity investment firm, for US$ 530 million in an all cash sale. The pu...

Drugs and Medications [236 Associated Drugs and Medications listed on BioPortfolio]

Antimicrobial [Safetec of America]

Antimicrobial

A.b.h.c. instant hand sanitizer citrus scent [Safetec of America, Inc.]

A.B.H.C. INSTANT HAND SANITIZER

Hydrocortisone [Safetec of America, Inc.]

Safetec First Aid 1% Hydrocortisone Cream

Analgesic [Safetec of America, Inc.]

Safetec of America, Inc. PAIN SPRAY

Antiseptic [Safetec of America]

ANTISEPTIC – Benzalkonium chloride liquid Safetec of America

PubMed Articles [3147 Associated PubMed Articles listed on BioPortfolio]

Response of cord blood cells to environmental, hereditary and perinatal factors: A prospective birth cohort study.

Many studies investigating the impact of individual risk factors on cord blood immune cell counts may be biased given that cord blood composition is influenced by a multitude of factors. The aim of th...

Evaluating Otherwise-Discarded Umbilical Cord Blood as a Source for a Neonate's Complete Blood Cell Count at Various Time Points.

Previous studies have reported the use of cord blood for admission laboratory complete blood counts (CBCs). However, no studies have investigated its stability for the first 30 min after delivery.

Arterio-venous blood gas Δvalues for validation of umbilical cord blood samples at birth are biased not only by sample mix ups but also affected by clinical factors.

Traditional validation of umbilical cord blood samples with positive veno-arterial (V-A) ΔpH and A-V ΔpCO values confirms the source of samples, where negative Δvalues represent mix-up of samples. ...

Successful engraftment after cord blood transplantation from an HLA-homozygous donor (homo-to-hetero cord blood transplantation) in a primary myelofibrosis patient with broad HLA antibodies.

Donor-specific human leukocyte antigen (HLA) antibodies are a significant risk factor for graft failure in cord blood transplantation (CBT). Although there are several treatments to decrease HLA antib...

Dexmedetomidine Preconditioning Ameliorates Inflammation and Blood-Spinal Cord Barrier Damage after Spinal Cord Ischemia-Reperfusion Injury by Down-Regulation High Mobility Group Box 1-Toll-Like Receptor 4-Nuclear Factor κB Signaling Pathway.

To evaluate the effect of Dexmedetomidine (Dex) on the inflammatory response and the integrity of blood-spinal cord barrier (BSCB) after spinal cord ischemia-reperfusion injury (SCIRI).

Clinical Trials [5268 Associated Clinical Trials listed on BioPortfolio]

A Myeloablative Conditioning Regimen and Total Body Irradiation Followed by the Transplantation for Patients With Hematological Malignancy

In this study two cord blood collections will be used to increase the number of cord blood cells you will receive on transplant day. We call this a "double unit" cord blood transplant. A p...

Centralized Cord Blood Registry to Facilitate Unrelated Cord Blood Transplantation

The National Marrow Donor Program (NMDP) has established a system for registering, matching, and tracking unrelated donor cord blood units (CBUs) and transplant outcomes. Study subjects a...

Transplants With Unlicensed Preserved Cord Blood

Background: - Cord blood transplants can treat cancers and other diseases in children and adults. The U.S. Food and Drug Administration (FDA) requires cord blood to be collected and store...

Transplantation of Umbilical Cord Blood Following Chemotherapy for Blood Cancers

This study is to evaluate the safety of transplantation of two cord blood products, including toxicities in patients following high-dose, myeloablative chemotherapy for blood malignancies....

Phase I Study of Sequential Cord Blood Transplants

The purpose of this study is to determine the safety of sequential cord blood transplantation (2 cord blood units) for patients who have diseases that are capable of being cured by allogen...

Companies [1700 Associated Companies listed on BioPortfolio]

Cord Blood America, Inc.

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected ste...

Cord Blood America

Cord Blood America's mission is to be the most respected stem cell preservation company in the world. Cord Blood America will achieve its mission through educating expectant parents, families with a h...

China Cord Blood Corporation

China Cord Blood Corporation is the first and the largest cord blood banking operator in China in terms of geographical coverage and is the only cord blood bank operator with multiple licenses. Un...

Cleveland Cord Blood Center

Following the delivery of a full-term newborn and collection of cord blood, a CCBC nurse collection coordinator at each hospital ensures that the cord blood is safely transported to the CCBC's 5,000 s...

Nohla Therapeutics Inc.

Nohla’s goal is to transform the medical care options for patients with our expanded cord blood product. The proprietary expansion platform multiplies the number of stem cell...

More Information about "Cord Blood America" on BioPortfolio

We have published hundreds of Cord Blood America news stories on BioPortfolio along with dozens of Cord Blood America Clinical Trials and PubMed Articles about Cord Blood America for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cord Blood America Companies in our database. You can also find out about relevant Cord Blood America Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record